Flow cytometry tests confirmed the high expression of CCR2 in CD45+EPCs in the HCC microenvironment of humans and mice, as well as CD45+EPCs in mouse HCC tissues (Figure 2C-D, Figure S6). This evidence concerns the gene CCR2 and hepatocellular carcinoma.